Free Trial
NASDAQ:BFRI

Biofrontera (BFRI) Stock Price, News & Analysis

Biofrontera logo
$0.85 -0.01 (-0.99%)
Closing price 04:00 PM Eastern
Extended Trading
$0.88 +0.02 (+2.76%)
As of 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Biofrontera Stock (NASDAQ:BFRI)

Key Stats

Today's Range
$0.84
$0.92
50-Day Range
$0.60
$1.11
52-Week Range
$0.54
$2.22
Volume
61,974 shs
Average Volume
353,836 shs
Market Capitalization
$8.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.75
Consensus Rating
Buy

Company Overview

Biofrontera Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

BFRI MarketRank™: 

Biofrontera scored higher than 62% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Biofrontera has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Biofrontera has received no research coverage in the past 90 days.

  • Read more about Biofrontera's stock forecast and price target.
  • Percentage of Shares Shorted

    2.14% of the float of Biofrontera has been sold short.
  • Short Interest Ratio / Days to Cover

    Biofrontera has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biofrontera has recently decreased by 17.05%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Biofrontera does not currently pay a dividend.

  • Dividend Growth

    Biofrontera does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.14% of the float of Biofrontera has been sold short.
  • Short Interest Ratio / Days to Cover

    Biofrontera has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biofrontera has recently decreased by 17.05%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Biofrontera has a news sentiment score of 1.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Biofrontera this week, compared to 1 article on an average week.
  • Search Interest

    Only 2 people have searched for BFRI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Biofrontera to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Biofrontera insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.80% of the stock of Biofrontera is held by insiders.

  • Percentage Held by Institutions

    Only 10.08% of the stock of Biofrontera is held by institutions.

  • Read more about Biofrontera's insider trading history.
Receive BFRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biofrontera and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BFRI Stock News Headlines

Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure. SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation.tc pixel
Biofrontera Revenue Jumps 15% in Q2
Biofrontera Q2 Revenue Jumps 15%
See More Headlines

BFRI Stock Analysis - Frequently Asked Questions

Biofrontera's stock was trading at $1.09 at the beginning of the year. Since then, BFRI stock has decreased by 21.9% and is now trading at $0.8515.

Biofrontera Inc. (NASDAQ:BFRI) posted its quarterly earnings data on Wednesday, August, 13th. The company reported ($0.57) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.45) by $0.12. The firm had revenue of $9.03 million for the quarter, compared to analyst estimates of $8.30 million. Biofrontera had a negative trailing twelve-month return on equity of 1,104.09% and a negative net margin of 42.34%.
Read the conference call transcript
.

Biofrontera's stock reverse split on Wednesday, July 5th 2023.The 1-20 reverse split was announced on Wednesday, July 5th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 5th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Biofrontera (BFRI) raised $19 million in an initial public offering on Friday, October 29th 2021. The company issued 3,100,000 shares at $5.00-$7.00 per share. Roth Capital Partners and The Benchmark Company served as the underwriters for the IPO.

Biofrontera's top institutional shareholders include Rosalind Advisors Inc. (9.63%) and AIGH Capital Management LLC (9.61%).

Shares of BFRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biofrontera investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), AST SpaceMobile (ASTS), NVIDIA (NVDA), NIO (NIO) and Meta Platforms (META).

Company Calendar

Last Earnings
8/13/2025
Today
8/28/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BFRI
CIK
1858685
Fax
N/A
Employees
70
Year Founded
N/A

Price Target and Rating

High Price Target
$2.75
Low Price Target
$2.75
Potential Upside/Downside
+223.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.26)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$17.76 million
Net Margins
-42.34%
Pretax Margin
-42.29%
Return on Equity
-1,104.09%
Return on Assets
-82.28%

Debt

Debt-to-Equity Ratio
8.99
Current Ratio
0.96
Quick Ratio
0.75

Sales & Book Value

Annual Sales
$37.32 million
Price / Sales
0.23
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.46) per share
Price / Book
-1.85

Miscellaneous

Outstanding Shares
10,140,000
Free Float
9,652,000
Market Cap
$8.63 million
Optionable
No Data
Beta
0.50

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:BFRI) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners